Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?

The stock's yield is more than six times the S&P 500 average.

CryptoAlerta — análise de criptomoedas e mercado em tempo real